ArticleEuropean radiology2023
Head and neck MRI-based T stage and [
Abstract read
In one paragraph
Article in European radiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 6 citations in OpenAlex.
- Application of Digital Medicine to the Diagnosis and Treatment of Head and Neck Tumors.Cancer reports (Hoboken, N.J.) · 2026Review
- Prospective Head-to-Head Comparison ofRadiology. Imaging cancer · 2026Article
- Diagnostic and Economic Evaluation of [Journal of clinical medicine · 2026Article
- [A deep learning method for differentiating nasopharyngeal carcinoma and lymphoma based on MRI].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2025Article
- Radiologic Predictors of Disease Recurrence in Nasopharyngeal Carcinoma: A Retrospective Evaluation of MRI andDiagnostics (Basel, Switzerland) · 2025Article
- Intravoxel incoherent motion diffusion-weighted imaging (IVIM-DWI) combined with conventional MRI for the detection of skull-base invasion in nasopharyngeal carcinoma: comparison withQuantitative imaging in medicine and surgery · 2024Article
- MRI and PET/CT in the assessment of lymph node metastases in head and neck cancer.Scientific reports · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors at 4 institutions in 1 country.
Hao-Jun XieSun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, 510060, Guangzhou, China.
Xue-Song SunSun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, 510060, Guangzhou, China.
Xu ZhangSun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, 510060, Guangzhou, China.
Bei-Bei XiaoSun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, 510060, Guangzhou, China.
Da-Feng LinSun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, 510060, Guangzhou, China.
Xiao-Ping LinSun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, 510060, Guangzhou, China.
Xiao-Fei LvSun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, 510060, Guangzhou, China.
Li-Zhi LiuSun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, 510060, Guangzhou, China.
Feng HanSun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, 510060, Guangzhou, China.
Ru-Hai ZouSun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, 510060, Guangzhou, China.
Ji-Bin LiSun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, 510060, Guangzhou, China.
Wei FanSun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, 510060, Guangzhou, China.
Qiu-Yan ChenSun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, 510060, Guangzhou, China.
Hai-Qiang MaiSun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, 510060, Guangzhou, China. maihq@sysucc.org.cn.
Lin-Quan TangSun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, 510060, Guangzhou, China. tanglq@sysucc.org.cn.
Sun Yat-sen University · CNState Key Laboratory of Oncology in South ChinaKey Laboratory of Guangdong Province · CNSun Yat-sen University Cancer Center · CN
Funding
Guangdong Major Project of Basic and Applied Basic Research HRB103Guangzhou Science and Technology Program (CN) 202201011561Health Medical Collaborative Innovation Program of Guangzhou No. 201400000001Health Medical Collaborative Innovation Program of Guangzhou No.201803040003Innovative Research Team of High-level Local Universities in Shanghai SSMU-ZLCX20180500Key Technologies Research and Development Program SQ2022YFC2500174Key Youth Teacher Cultivating Program of Sun Yat-sen University 20ykzd24National Natural Science Foundation of China 82002852National Natural Science Foundation of China 82003267National Natural Science Foundation of China 82073003National Natural Science Foundation of China 82173287National Natural Science Foundation of China 82203125National Natural Science Foundation of China 82203776National Natural Science Foundation of China 82222050National Natural Science Foundation of China 82272739National Natural Science Foundation of China 82272882National Natural Science Foundation of China No. 32200651National Science and Technology Program during the Twelfth Five-year Plan Period No. 2014BAI09B10Natural Science Foundation of Guangdong Province No.2017A030312003Natural Science Foundation of Guangdong Province No.2018A0303131004Pearl River S and T Nova Program of Guangzhou No. 201806010135Postdoctoral Innovative Talent Support Program BX20220361Science and Technology Planning Project of Guangdong Province No. 2014A020212103the Natural Science Foundation of Guangdong Province for Distinguished Young Scholar No.2018B030306001the Planned Science and Technology Project of Guangdong Province 2019B020230002the Special Support Plan of Guangdong Province No. 2014TX01R145the Sun Yat-sen University Clinical Research 5010 Program, the Special Support Plan of Guangdong Province 2015021the Sun Yat-sen University Clinical Research 5010 Program, the Special Support Plan of Guangdong Province 2017010the Sun Yat-sen University Clinical Research 5010 Program, the Special Support Plan of Guangdong Province 2019023the Sun Yat-sen University Clinical Research 5010 Program, the Special Support Plan of Guangdong Province No. 201315
Abstract
objectivesTo evaluate whether MRI-based T stage (T
methodsFrom April 2007 to December 2013, 1013 consecutive untreated NPC patients with complete imaging data were enrolled. All patients' initial stages were repeated based on (1) the NCCN guideline recommended "T
results[
conclusionsThe MRI is superior to [ CLINICAL RELEVANCE STATEMENT: The present research provided long-term follow-up evidence for benefits of MRI and [ KEY POINTS: • The long-term follow-up evidence of a large-scale cohort was provided to evaluate the advantages of MRI, [
Indexed as
Nasopharyngeal NeoplasmsPositron Emission Tomography Computed TomographyFluorodeoxyglucose F18HumansMagnetic Resonance ImagingNasopharyngeal CarcinomaNeoplasm StagingPositron-Emission TomographyPrognosisRadiopharmaceuticalsFluorodeoxyglucose F18Radiopharmaceuticals[18F]Fluorodeoxyglucose positron emission tomography and computed tomographyMagnetic resonance imagingNasopharyngeal carcinoma
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.